Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine and Megestrol Acetate for Cancer Anorexia-cachexia
NCT01501396Phase 2Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2013
- Primary completion
- Sep 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of mirtazapine in cancer anorexia-cachexia syndrome (CACS), sponsored by Washington University School of Medicine. Planned start Sep 2013; status: withdrawn.
02
Drugs
mirtazapine
03
Conditions
cancer anorexia-cachexia syndrome (CACS)
Beyond the preview
Go deeper on NCT01501396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01501396.